RE:RE:RE:RE:Pulling this downAll rumours aside, we will need cash sooner or later, this is normal course of business, lets hope for a higher price and less dilution. perhaps the price goes up and warrants bring some cash in while we wait for more data from our Chicago trial, more amazing data will move the price eventually! as the science looks very positive and the market will take notice...or a pharma with deep pockets may form a collabaration of some kind. At any rate we also have other applications that may also garner a partnership of some fashion. It is my opinion that Sernovas share structure is still fairly tight considering where we are with the pouch development and where we are going. If the price goes down it wont be for long. My biggest problem is finding more cash to buy more at these fire sale prices. Re read our hemo 20/20 horizon data and our data from Lyon France you may find you have my problem as well. To all the longs...Kudos!!